Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study

Fumihiko Urabe, Yuki Taneda, Naoki Uchida, Hirokazu Kagawa, Katsuki Muramoto, Yuma Goto, Yuhei Koike, Shuhei Hara, Takashi Ohtsuka, Minoru Nakazono, Mimu Ishikawa, Yu Imai, Kosuke Iwatani, Sotaro Kayano, Mahito Atsuta, Koichi Aikawa, Kojiro Tashiro, Takaya Sasaki, Jun Miki, Takahiro Kimura, Unknown

Open source

DOI: 10.1093/jjco/hyaf060
Published: 2025-04-08
Container: Japanese Journal of Clinical Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jjco/hyaf060,
  title = {Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study},
  author = {Fumihiko Urabe and Yuki Taneda and Naoki Uchida and Hirokazu Kagawa and Katsuki Muramoto and Yuma Goto and Yuhei Koike and Shuhei Hara and Takashi Ohtsuka and Minoru Nakazono and Mimu Ishikawa and Yu Imai and Kosuke Iwatani and Sotaro Kayano and Mahito Atsuta and Koichi Aikawa and Kojiro Tashiro and Takaya Sasaki and Jun Miki and Takahiro Kimura and Unknown},
  year = {2025},
  journal = {Japanese Journal of Clinical Oncology},
  doi = {10.1093/jjco/hyaf060},
  url = {https://doi.org/10.1093/jjco/hyaf060}
}

RIS

TY  - JOUR
TI  - Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study
AU  - Fumihiko Urabe
AU  - Yuki Taneda
AU  - Naoki Uchida
AU  - Hirokazu Kagawa
AU  - Katsuki Muramoto
AU  - Yuma Goto
AU  - Yuhei Koike
AU  - Shuhei Hara
AU  - Takashi Ohtsuka
AU  - Minoru Nakazono
AU  - Mimu Ishikawa
AU  - Yu Imai
AU  - Kosuke Iwatani
AU  - Sotaro Kayano
AU  - Mahito Atsuta
AU  - Koichi Aikawa
AU  - Kojiro Tashiro
AU  - Takaya Sasaki
AU  - Jun Miki
AU  - Takahiro Kimura
AU  - Unknown
PY  - 2025
JO  - Japanese Journal of Clinical Oncology
DO  - 10.1093/jjco/hyaf060
UR  - https://doi.org/10.1093/jjco/hyaf060
ER  -

APA

Urabe, F., Taneda, Y., Uchida, N., Kagawa, H., Muramoto, K., Goto, Y., Koike, Y., Hara, S., Ohtsuka, T., Nakazono, M., Ishikawa, M., Imai, Y., Iwatani, K., Kayano, S., Atsuta, M., Aikawa, K., Tashiro, K., Sasaki, T., Miki, J., Kimura, T., & Unknown (2025). Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf060

Source records

crossref · retrieved 2026-09-27T02:56:20.544Z